Table of Contents Author Guidelines Submit a Manuscript
Letter to the Editor
Mediators of Inflammation
Volume 2013, Article ID 635672, 10 pages
http://dx.doi.org/10.1155/2013/635672
Research Article

Circulating Th22 and Th9 Levels in Patients with Acute Coronary Syndrome

1Department of Cardiology, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China
2Institute of Cardiovascular Diseases, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China
3Department of Ultrasound, The People’s Hospital of Guangxi Zhuang Autonomous Region, Nanning, China

Received 19 August 2013; Revised 6 November 2013; Accepted 10 November 2013

Academic Editor: Ronald Gladue

Copyright © 2013 Ying-zhong Lin et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. G. K. Hansson and A. Hermansson, “The immune system in atherosclerosis,” Nature Immunology, vol. 12, no. 3, pp. 204–212, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Lahoute, O. Herbin, Z. Mallat, and A. Tedgui, “Adaptive immunity in atherosclerosis: mechanisms and future therapeutic targets,” Nature Reviews Cardiology, vol. 8, no. 6, pp. 348–358, 2011. View at Publisher · View at Google Scholar · View at Scopus
  3. C. M. Weyand, J. J. Goronzy, G. Liuzzo, S. L. Kopecky, and D. R. Holmes Jr., “T-cell immunity in acute coronary syndromes,” Mayo Clinic Proceedings, vol. 76, no. 10, pp. 1011–1020, 2001. View at Publisher · View at Google Scholar
  4. A.-K. L. Robertson and G. K. Hansson, “T cells in atherogenesis: for better or for worse?” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 26, no. 11, pp. 2421–2432, 2006. View at Publisher · View at Google Scholar · View at Scopus
  5. J. Frostegard, A. K. Ulfgren, P. Nyberg et al., “Cytokine expression in advanced human atherosclerotic plaques: dominance of pro-inflammatory (Th1) and macrophage-stimulating cytokines,” Atherosclerosis, vol. 145, no. 1, pp. 33–43, 1999. View at Google Scholar
  6. A. Yilmaz, M. Lochno, F. Traeg et al., “Emergence of dendritic cells in rupture-prone regions of vulnerable carotid plaques,” Atherosclerosis, vol. 176, no. 1, pp. 101–110, 2004. View at Google Scholar
  7. H. Methe, S. Brunner, D. Wiegand, M. Nabauer, J. Koglin, and E. R. Edelman, “Enhanced T-helper-1 lymphocyte activation patterns in acute coronary syndromes,” Journal of the American College of Cardiology, vol. 45, no. 12, pp. 1939–1945, 2005. View at Publisher · View at Google Scholar
  8. X. Cheng, Y. Chen, J. J. Xie et al., “Suppressive oligodeoxynucleotides inhibit atherosclerosis in ApoE(−/−) mice through modulation of Th1/Th2 balance,” Journal of Molecular and Cellular Cardiology, vol. 45, no. 2, pp. 168–175, 2008. View at Google Scholar
  9. S. C. Whitman, P. Ravisankar, H. Elam, and A. Daugherty, “Exogenous interferon-γ enhances atherosclerosis in apolipoprotein E−/− mice,” American Journal of Pathology, vol. 157, no. 6, pp. 1819–1824, 2000. View at Google Scholar · View at Scopus
  10. R. E. Eid, D. A. Rao, J. Zhou et al., “Interleukin-17 and interferon-gamma are produced concomitantly by human coronary artery-infiltrating T cells and act synergistically on vascular smooth muscle cells,” Circulation, vol. 119, no. 10, pp. 1424–1432, 2009. View at Google Scholar
  11. C. Erbel, L. Chen, F. Bea et al., “Inhibition of IL-17A attenuates atherosclerotic lesion development in apoE-deficient mice,” The Journal of Immunology, vol. 183, no. 12, pp. 8167–8175, 2009. View at Publisher · View at Google Scholar
  12. E. Smith, K. M. Prasad, M. Butcher et al., “Blockade of interleukin-17A results in reduced atherosclerosis in apolipoprotein E-deficient mice,” Circulation, vol. 121, no. 15, pp. 1746–1755, 2010. View at Publisher · View at Google Scholar
  13. K. Danzaki, Y. Matsui, M. Ikesue et al., “Interleukin-17A deficiency accelerates unstable atherosclerotic plaque formation in apolipoprotein E-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 32, no. 2, pp. 273–280, 2012. View at Publisher · View at Google Scholar
  14. M. J. Butcher, B. N. Gjurich, T. Phillips, and E. V. Galkina, “The IL-17A/IL-17RA axis plays a proatherogenic role via the regulation of aortic myeloid cell recruitment,” Circulation Research, vol. 110, no. 5, pp. 675–687, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. F. Usui, H. Kimura, T. Ohshiro et al., “Interleukin-17 deficiency reduced vascular inflammation and development of atherosclerosis in Western diet-induced apoE-deficient mice,” Biochemical and Biophysical Research Communications, vol. 420, no. 1, pp. 72–77, 2012. View at Google Scholar
  16. M. S. Madhur, S. A. Funt, L. Li et al., “Role of interleukin 17 in inflammation, atherosclerosis, and vascular function in apolipoprotein e-deficient mice,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 31, no. 7, pp. 1565–1572, 2011. View at Publisher · View at Google Scholar
  17. H. Ait-Oufella, B. L. Salomon, S. Potteaux et al., “Natural regulatory T cells control the development of atherosclerosis in mice,” Nature Medicine, vol. 12, no. 2, pp. 178–180, 2006. View at Publisher · View at Google Scholar
  18. A. Mor, D. Planer, G. Luboshits et al., “Role of naturally occurring CD4+ CD25+ regulatory T cells in experimental atherosclerosis,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 27, no. 4, pp. 893–900, 2007. View at Publisher · View at Google Scholar
  19. Y. Zhong, X. Wang, Q. Ji et al., “CD4+LAP+ and CD4+CD25+Foxp3+ regulatory T cells induced by nasal oxidized low-density lipoprotein suppress effector T cells response and attenuate atherosclerosis in ApoE−/− mice,” Journal of Clinical Immunology, vol. 32, no. 5, pp. 1104–1117, 2012. View at Publisher · View at Google Scholar
  20. Z. Mallat, A. Gojova, V. Brun et al., “Induction of a regulatory T cell type 1 response reduces the development of atherosclerosis in apolipoprotein E-knockout mice,” Circulation, vol. 108, no. 10, pp. 1232–1237, 2003. View at Publisher · View at Google Scholar
  21. Q. W. Ji, M. Guo, J. S. Zheng et al., “Downregulation of T helper cell type 3 in patients with acute coronary syndrome,” Archives of Medical Research, vol. 40, no. 4, pp. 285–293, 2009. View at Publisher · View at Google Scholar
  22. V. Dardalhon, A. Awasthi, H. Kwon et al., “IL-4 inhibits TGF-beta-induced Foxp3+ T cells and, together with TGF-beta, generates IL-9+ IL-10+ Foxp3(-) effector T cells,” Nature Immunology, vol. 9, no. 12, pp. 1347–1355, 2008. View at Google Scholar
  23. M. Veldhoen, C. Uyttenhove, J. van Snick et al., “Transforming growth factor-beta “reprograms” the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset,” Nature Immunology, vol. 9, no. 12, pp. 1341–1346, 2008. View at Google Scholar
  24. S. Trifari, C. D. Kaplan, E. H. Tran, N. K. Crellin, and H. Spits, “Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells,” Nature Immunology, vol. 10, no. 8, pp. 864–871, 2009. View at Publisher · View at Google Scholar · View at Scopus
  25. T. Duhen, R. Geiger, D. Jarrossay, A. Lanzavecchia, and F. Sallusto, “Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells,” Nature Immunology, vol. 10, no. 8, pp. 857–863, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. R. Basu, D. B. O'Quinn, D. J. Silberger et al., “Th22 cells are an important source of IL-22 for host protection against enteropathogenic bacteria,” Immunity, vol. 37, no. 6, pp. 1061–1075, 2012. View at Google Scholar
  27. A. Jäger, V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo, “Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes,” Journal of Immunology, vol. 183, no. 11, pp. 7169–7177, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. Z. J. Ye, M. L. Yuan, Q. Zhou et al., “Differentiation and recruitment of Th9 cells stimulated by pleural mesothelial cells in human Mycobacterium tuberculosis infection,” PloS ONE, vol. 7, no. 2, Article ID e31710, 2012. View at Google Scholar
  29. M.-E. Truchetet, N. C. Brembilla, E. Montanari, Y. Allanore, and C. Chizzolini, “Increased frequency of circulating Th22 in addition to Th17 and Th2 lymphocytes in systemic sclerosis: association with interstitial lung disease,” Arthritis Research & Therapy, vol. 13, no. 5, p. R166, 2011. View at Publisher · View at Google Scholar · View at Scopus
  30. L. Zhang, Y. G. Li, Y. H. Li et al., “Increased frequencies of Th22 cells as well as Th17 cells in the peripheral blood of patients with ankylosing spondylitis and rheumatoid arthritis,” PloS ONE, vol. 7, no. 4, Article ID e31000, 2012. View at Google Scholar
  31. Q. Xia, X. Xiang, S. Patel, R. Puranik, Q. Xie, and S. Bao, “Characterisation of IL-22 and interferon-gamma-inducible chemokines in human carotid plaque,” International Journal of Cardiology, vol. 154, no. 2, pp. 187–189, 2012. View at Publisher · View at Google Scholar
  32. R. T. Oliveira, R. M. Silva, F. H. Teo et al., “Detection of TCD4+ subsets in human carotid atheroma,” Cytokine, vol. 62, no. 1, pp. 131–140, 2013. View at Google Scholar
  33. I. Gregersen, M. Skjelland, S. Holm et al., “Increased systemic and local interleukin 9 levels in patients with carotid and coronary atherosclerosis,” PLoS ONE, vol. 8, no. 8, Article ID e72769, 2013. View at Google Scholar
  34. H. Chang, H. Hanawa, H. Liu et al., “Hydrodynamic-based delivery of an interleukin-22-Ig fusion gene ameliorates experimental autoimmune myocarditis in rats,” The Journal of Immunology, vol. 177, no. 6, pp. 3635–3643, 2006. View at Google Scholar
  35. K. Wolk, E. Witte, K. Witte, K. Warszawska, and R. Sabat, “Biology of interleukin-22,” Seminars in Immunopathology, vol. 32, no. 1, pp. 17–31, 2010. View at Google Scholar
  36. L. Geboes, L. Dumoutier, H. Kelchtermans et al., “Proinflammatory role of the Th17 cytokine interleukin-22 in collagen-induced arthritis in C57BL/6 mice,” Arthritis and Rheumatism, vol. 60, no. 2, pp. 390–395, 2009. View at Publisher · View at Google Scholar · View at Scopus
  37. X. Y. Yang, H. Y. Wang, X. Y. Zhao, L. J. Wang, Q. H. Lv, and Q. Q. Wang, “Th22, but not Th17 might be a good index to predict the tissue involvement of systemic lupus erythematosus,” Journal of Clinical Immunology, vol. 33, no. 4, pp. 767–774, 2013. View at Google Scholar
  38. T. Liu, L. Peng, P. Yu et al., “Increased circulating Th22 and Th17 cells are associated with tumor progression and patient survival in human gastric cancer,” Journal of Clinical Immunology, vol. 32, no. 6, pp. 1332–1339, 2012. View at Google Scholar
  39. D. Whiting, G. Hsieh, J. J. Yun et al., “Chemokine monokine induced by IFN-gamma/CXC chemokine ligand 9 stimulates T lymphocyte proliferation and effector cytokine production,” The Journal of Immunology, vol. 172, no. 12, pp. 7417–7424, 2004. View at Google Scholar
  40. N. R. Madamanchi, S. Li, C. Patterson, and M. S. Runge, “Reactive oxygen species regulate heat-shock protein 70 via the JAK/STAT pathway,” Arteriosclerosis, Thrombosis, and Vascular Biology, vol. 21, no. 3, pp. 321–326, 2001. View at Google Scholar · View at Scopus
  41. A. H. Sprague and R. A. Khalil, “Inflammatory cytokines in vascular dysfunction and vascular disease,” Biochemical Pharmacology, vol. 78, no. 6, pp. 539–552, 2009. View at Publisher · View at Google Scholar · View at Scopus
  42. A. Tedgui and Z. Mallat, “Cytokines in atherosclerosis: pathogenic and regulatory pathways,” Physiological Reviews, vol. 86, no. 2, pp. 515–581, 2006. View at Publisher · View at Google Scholar · View at Scopus
  43. H. C. Chang, S. Sehra, R. Goswami et al., “The transcription factor PU. 1 is required for the development of IL-9-producing T cells and allergic inflammation,” Nature Immunology, vol. 11, no. 6, pp. 527–534, 2010. View at Google Scholar
  44. M. H. Kaplan, “Th9 cells: differentiation and disease,” Immunological Reviews, vol. 252, no. 1, pp. 104–115, 2013. View at Google Scholar
  45. H. Li and A. Rostami, “IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity,” Journal of Neuroimmune Pharmacology, vol. 5, no. 2, pp. 198–209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  46. V. Staudt, E. Bothur, M. Klein et al., “Interferon-regulatory factor 4 is essential for the developmental program of T helper 9 cells,” Immunity, vol. 33, no. 2, pp. 192–202, 2010. View at Publisher · View at Google Scholar
  47. Y. Lu, S. Hong, H. Li et al., “Th9 cells promote antitumor immune responses in vivo,” The Journal of Clinical Investigation, vol. 122, no. 11, pp. 4160–4171, 2012. View at Publisher · View at Google Scholar